NCT02912767CompletedNot Applicable
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Memorial Sloan Kettering Cancer Center1 site in 1 country625 target enrollmentStarted: July 20, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 625
- Locations
- 1
- Primary Endpoint
- compare lymphedema prevalence
Study Overview
Brief Summary
The investigators are interested in understanding how the patient has been doing since their surgery for endometrial cancer and if they are experiencing any symptoms related to lymphedema (swelling) in the your lower body. The investigators hope that information from the patient and others will help them improve care for women treated for endometrial cancer.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Presented to MSK with newly diagnosed endometrial carcinoma of any histologic profile clinically confined to the uterus and/or uterine cervix
- •Underwent primary surgery at our institution, to include at least a total hysterectomy via laparotomy, laparoscopy, or robotic approach, between January 2006 and December 2013
- •Alive at the time of study activation
Exclusion Criteria
- •Had documented macroscopic evidence of extrauterine disease at the time of initial diagnosis
Outcomes
Primary Outcomes
compare lymphedema prevalence
Time Frame: 1 year
Data from respondents will be analyzed to determine prevalence of patient reported lymphedema overall; these will then be compared to the prevalence among those who underwent SLN mapping alone, or a comprehensive pelvic lymphadenectomy (+/- para-aortic LND and +/-SLN mapping in conjunction).
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node DissectionBreast CancerNCT01969253National Cancer Center, Korea400
Completed
Not Applicable
Prospective Measurement of Post-Treatment LymphedemaMelanomaNCT00495950M.D. Anderson Cancer Center350
Completed
Not Applicable
Prospective Evaluation of Lymphoedema Among Patients With Gynaecological CancerFemale Genital DiseasesEndometrial CancerVulval CancerOvarian CancerCervical CancerNCT00604994Queensland Centre for Gynaecological Cancer761
Completed
Not Applicable
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar CancerCervical CancerVulvar CancerNCT05255393Memorial Sloan Kettering Cancer Center111
Suspended
Not Applicable
Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile CancerPenile CancerNCT05842031M.D. Anderson Cancer Center20